(Press-News.org)
A unique group of life science professionals and advocates has come together to launch the Minoritised Life Scientists Future Forum, the first major conference in Europe dedicated to supporting and showcasing the contributions of marginalised and underrepresented communities in the life sciences.
Taking place at the ICC Birmingham from 31 March to 2 April 2025, the Future Forum will offer over 200 hours of inspiring talks, workshops, and mentoring sessions. The event is designed for life scientists at all career stages from undergraduate students to early-career researchers and senior academics, aiming to build a vibrant and supportive environment for professional development and networking.
The forum comes at a critical time for the sector. Despite increasing diversity among students entering higher education, Black scientists still make up just 0.8% of all professors in the UK, according to the latest figures 1. Black academics make up just 2.9% of academics in research-focused roles, with many citing unconscious bias (54%) and unclear promotion pathways (52%) as major barriers to career progression. In addition, 42% of Black early-career academics (ECAs) report not feeling comfortable reporting incidents of bullying or harassment at their institutions.
Beyond the statistics, minoritised scientists frequently report feeling invisible within academia, often missing out on opportunities for collaboration and career progression due to microaggressions and lack of mentoring. For undergraduate students, the lack of visible role models and a clear pathway into academia can make the goal of a research career seem unattainable. The Future Forum aims to address these systemic barriers by providing a platform for visibility, mentorship, and professional growth, helping to bridge the gap between students and established academics.
Professor Emmanuel Adukwu, Chair of the Future Forum Steering Committee, expressed his excitement for the event:
“The underrepresentation of minoritised scientists in senior roles is a major concern for the future of UK science. While efforts have been made to tackle these inequalities, we must create spaces that build genuine connections, mentorship, and opportunities for collaboration across all career stages. This forum is not just about sharing research; it’s about creating a lasting impact that helps marginalised and underrepresented scientists thrive in academia and beyond.”
The three-day event will feature talks, networking sessions, and workshops led by scientists from a range of disciplines. Delegates will have the opportunity to showcase their research, engage in structured networking, take part in career development workshops, and find mentorship from experienced professionals. Additionally, the forum will serve as a space for open discussions on challenges such as unconscious bias, lack of institutional support, and career progression barriers.
The Minoritised Life Scientists Future Forum Steering Committee is currently seeking sponsors, exhibitors, and life scientists interested in delivering talks, leading workshops, or mentoring attendees. To find out more and sign up for updates, visit the Future Forum website at www.mlsfutureforum.com, and follow us on Instagram (www.instagram.com/mlsfutureforum) and X (@MLSFutureForum) for the latest announcements.
The Future Forum is made possible through major funding support from the Medical Research Council (MRC) and the Wellcome Trust.
For more information or to arrange interviews with members of the steering committee, contact Linda Stewart or Paul Sainsbury at press@mlsfutureforum.com or 07432 212326.
Figures from ‘Unblocking the Pipeline: Supporting the Retention, Progression and Promotion of Black Early-Career Academics’ , HEPI Report 176, Dr Becca Franssen, GatenbySanderson
Notes to Editors
About the Medical Research Council (MRC)
The Medical Research Council (MRC) is at the forefront of funding research to prevent illness, develop new therapies, and improve human health. With a focus on biomedical research, MRC supports projects ranging from lab-based studies to clinical trials across all major disease areas. It works closely with the NHS and UK health departments to ensure that its research translates into meaningful improvements in clinical practice and public health. As a major funder for the Minoritised Life Scientists Future Forum, MRC is committed to advancing equality and diversity in scientific research and promoting careers in life sciences for underrepresented communities.
About Wellcome
Wellcome is a global charitable foundation established in 1936, dedicated to supporting scientific research that addresses some of the world's most pressing challenges. Wellcome funds research into areas such as climate change, infectious diseases, and mental health. Through partnerships, policy work, and direct funding, Wellcome aims to ensure that scientific advances benefit everyone, everywhere. As a major funder for the Minoritised Life Scientists Future Forum, Wellcome’s support aligns with its commitment to promoting an inclusive and diverse research environment that drives innovative solutions in science and health. (www.wellcome.org)
About Applied Microbiology International (AMI)
AMI, a globally recognised leader in microbiology, is a strategic partner in delivering the Minoritised Life Scientists Future Forum. With a mission to advance applied microbiology and cultivate a diverse, inclusive scientific community, AMI serves microbiologists across academia, industry, and research institutes worldwide. In partnership with Oxford University Press, AMI publishes three leading scientific journals and leading industry magazine The Microbiologist, amplifying the voices of scientists and driving innovation within the field.
END
Europe’s First ever conference for minoritised life scientists set for Spring 2025
2024-10-17
ELSE PRESS RELEASES FROM THIS DATE:
mRNA vaccines for disease outbreaks can be synthesized in less time with new technique
2024-10-17
In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial. However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly synthesized using enzymes, a relatively slow process.
A team of researchers from Nagoya University in Japan has successfully developed an innovative synthesis technology capable of producing high purity, fully chemically ...
UK health leaders urge chancellor to invest in a smoke-free UK
2024-10-16
Over 200 leading doctors, professional bodies and charities are urging the chancellor to use the budget on 30 October to invest in creating a smoke free UK as quickly as possible, and make the tobacco industry pay.
In an open letter published by The BMJ today, they warn that unless smoking is addressed, there is no prospect of delivering on Labour’s manifesto commitment to halve the gap in healthy life expectancy between the richest and poorest regions.
The rationale for investing to end the tobacco epidemic could not be stronger, they explain. The annual cost of smoking to individuals, public ...
No link to birth defects for potential fathers taking metformin for diabetes
2024-10-16
Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million pregnancies published by The BMJ today.
The researchers say the findings show that metformin can continue to be considered a suitable drug for managing blood sugar levels in men with type 2 diabetes who plan on having children.
Metformin is widely used to treat type 2 diabetes in men of reproductive age, but a recent Danish study reported a link between metformin use by fathers-to-be and an increased ...
For multiple sclerosis, medication and cognitive behavioral therapy can reduce fatigue
2024-10-16
In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue, a University of Michigan-led study finds.
The randomized clinical trial compared the effectiveness of modafinil, a wake-promoting medication used to treat sleepiness in people with sleep disorders, and cognitive behavioral therapy, or CBT, on reducing fatigue for over 300 adults with multiple sclerosis whose symptoms interfered with their ...
Children with multiple long-term conditions hospitalized with COVID are almost three times more likely to die: New study
2024-10-16
Individuals with multiple long-term conditions are two and a half times more likely to die following COVID-19 infection than others. When children were assessed separately the risk for mortality among those with multiple long-term conditions increased to almost three times (2.8) the risk of those without. The mortality rates are 22% and 8% respectively.
That is according to an authoritative systematic review and meta-analysis of over four million patients with COVID-19 published today (Thursday 17 October) in the Journal of the Royal Society of Medicine.
The authors are calling for patients with multiple long-term conditions ...
8% GDP loss by 2050 foreseen due to world water crisis; more than 50% of food production at risk: Global Commission on the Economics of Water
2024-10-16
Paris — An international group of leaders and experts warns that unless humanity acts with greater boldness and urgency, an increasingly out-of-balance water cycle will wreak havoc on economies and humanity worldwide.
In a landmark report, The Economics of Water: Valuing the Hydrological Cycle as a Global Common Good, the Global Commission on the Economics of Water says the water crisis puts at risk more than half of the world’s food production by 2050. It also threatens an 8% loss of GDP in countries around the world on average by 2050, with as much ...
Nanoparticle therapy offers new hope for prostate cancer patients
2024-10-16
Prostate cancer is the second leading cause of cancer death among American men.
A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas and others, has demonstrated the clinical success of a new nanoparticle-based, laser-guided therapy for prostate cancer treatment.
The study, which involved 44 men with localized prostate cancer, used gold nanoshellss in combination with magnetic resonance imaging (MRI) and ultrasound fusion — an ...
UVA researchers engineer AI breakthrough in human action detection technology
2024-10-16
What if a security camera could not only capture video but understand what’s happening — distinguishing between routine activities and potentially dangerous behavior in real time? That’s the future being shaped by researchers at the University of Virginia’s School of Engineering and Applied Science with their latest breakthrough: an AI-driven intelligent video analyzer capable of detecting human actions in video footage with unprecedented precision and intelligence.
The system, called the Semantic and Motion-Aware Spatiotemporal Transformer Network (SMAST), promises a wide range of ...
Bolstering the fight against antibiotic-resistant bacteria
2024-10-16
GAINESVILLE, Fla. — University of Florida Health scientists exploring how combinations of antibiotics can fight resistant bacteria have been awarded an $11.8 million grant for work that could help save the tens of thousands of lives lost yearly to infections that are increasingly plaguing humanity.
The National Institutes of Health, or NIH, grant to the UF College of Medicine and the UF College of Pharmacy will support scientists working to uncover the mechanics of how bacteria and antibiotics interact, down to the molecular level.
That mechanistic knowledge ...
Deep learning illuminates atmospheric blocking events of past, future
2024-10-16
Atmospheric blocking events are persistent, high-impact weather patterns that occur when large-scale high-pressure systems become stationary and divert the jet stream and storm tracks for days to weeks, and can be associated with record-breaking flooding or heat waves, such as in Europe in 2023. In a new study, University of Hawai‘i at Mānoa atmospheric scientist Christina Karamperidou used a deep learning model to infer the frequency of blocking events over the past 1,000 years and shed light on how future climate change may impact these significant phenomena.
“This study set out to extract a paleoweather signal from ...